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Kaposi’s sarcoma-associated herpesvirus (KSHV) infection is associated with the development of Kaposi’s sarcoma, primary
effusion lymphoma, and multicentric Castleman’s disease. We report the establishment of a monocytic cell line latently infected
with KSHV (KSHV-THP-1). We profiled viral and cytokine gene expression in the KSHV-THP-1 cells compared to that in unin-
fected THP-1 cells and found that several genes involved in the host immune response were downregulated during latent infec-
tion, including genes for CD80, CD86, and the cytokines tumor necrosis factor alpha (TNF-) and interleukin-1 (IL-1). Thus,
KSHV minimizes its immunological signature by suppressing key immune response factors, enabling persistent infection and
evasion from host detection.
Kaposi’s sarcoma-associated herpesvirus (KSHV), also knownas human herpesvirus 8 (HHV8), is a member of the gamma-
herpesvirus subfamily. KSHV is the etiological agent of Kaposi’s
sarcoma (KS) (8), primary effusion lymphoma (PEL), and multi-
centric variant of Castleman’s disease (MCD) (1, 8, 36). KS is a
highly inflammatory and angiogenic vascular tumor defined by
characteristic spindle cells, which are believed to originate from
endothelial cells. PEL and MCD are both B cell lymphoprolifera-
tive diseases.
Like other herpesviruses, KSHV establishes latent infection in
its host. A number of PEL cell lines have been established where
most of the cells are latently infected, with only a small population
of cells undergoing spontaneous lytic reactivation (28, 38). Dur-
ing latency, a limited number of viral proteins are expressed, in-
cluding the latency-associated nuclear antigen (LANA), vFLIP,
vCyclin, kaposin, vIRF3, K1, and vIL-6 (7, 12, 35, 37). Mainte-
nance of the viral genome is absolutely dependent on the LANA
protein, which tethers the latent viral episome to the host cell
chromosome, ensuring that the viral genome is replicated with the
host genome and is not diluted out of the expanding population of
latently infected cells (10, 13). The LANA protein has been shown
to be expressed in latently infected B cells and endothelial cells, as
well as in the KSHV-positive tumors associated with these cell
types (3, 10, 13).
KSHV can successfully infect human monocytes and macro-
phages in vitro and in vivo (4–6, 24). Rappocciolo et al. demon-
strated that KSHV uses the receptor DC-SIGN to enter macro-
phages and dendritic cells (DCs) (31, 32). Kerur et al. showed that
in the THP-1 acute monocytic leukemia cell line, KSHV primary
infection was dependent on 31, v3, v5, and 51 integ-
rins and that it was preceded by endosomal entry, which activated
FAK, Src, PI3K, NF-B, and ERK1/2 signaling (20). Coinfection
of monocytes with KSHV and HIV increased the replication of
HIV in the presence of KSHV (6). Monocytes present in KS lesions
have been shown to support viral replication (5). Additionally,
KSHV has been found to infect CD34 stem cell precursors in
vitro, suggesting that stem cells or later-stage committed progen-
itor cells may be infected and subsequently differentiate into B
cells, monocytes, and other lineages to replenish depleted pools of
infected, differentiated cells (45).
Immunological detection of KSHV infection by T cells requires
T cell receptor (TCR) cognate interactions with the antigen-
presenting cell (APC) major histocompatibility complex (MHC)
surface molecules displaying KSHV peptide. On inactivated T
cells, CD28 is expressed at low levels. Upon TCR-MHC contact
and APC surface receptor CD40 ligation by CD40 ligand
(CD40L), CD28 expression is upregulated. Concomitantly, the
costimulatory molecules CD80 and CD86 on the APCs, which
interact with CD28 to increase the immune response, are upregu-
lated. Despite the existence of KSHV-specific T cells and immune
control in healthy individuals, latent virus is unable to be elimi-
nated from the host (41, 42). It is known that KSHV lytic proteins
K3 and K5 actively downregulate CD80 and MHC class I (MHC I)
surface expression; however, the suppression of adaptive immune
molecules during latency also contributes to evasion of the host
response (22). Cells involved in immunity that are tropic for
KSHV may facilitate suppression of host immune responses.
Given that KSHV infects monocytes in vivo, we established a
latently infected monocytic cell line by using the monocytic leu-
kemia cell line THP-1 to characterize viral gene expression in la-
tently infected monocytes (2, 39). THP-1 cells are susceptible to
human cytomegalovirus (HCMV) infection and support viral la-
tency (43). Importantly, although we have previously shown that
KSHV can infect primary human monocytes (44), we could not
establish a long-term latent culture in these cells because of the
primary nature of the monocytes. In contrast, THP-1 cells enable
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the establishment of a monocytic latent cell line that harbors
KSHV and which can be passaged over a long period.
MATERIALS AND METHODS
Production of recombinant rKSHV.219 virus. Vero cells containing la-
tent rKSHV.219 (KSHV-Vero) and a recombinant baculovirus KSHV
Orf50 (Bac50) were kindly provided by Jeffrey Vieira (40). rKSHV.219
expresses green fluorescent protein (GFP) and also contains a puromycin
resistance gene as a selectable marker. Insect SF9 cells were grown in
SF900-II serum-free medium at 28°C. SF9 cells were infected with bacu-
lovirus expressing KSHV Orf50 (Bac50) for 3 days, after which time the
baculovirus-containing supernatant was clarified by centrifugation (1,500
rpm for 10 min). KSHV-Vero cells were then infected with Bac50 and
treated with 2 mM sodium butyrate for 3 days. Supernatant was harvested,
and cells were removed by centrifugation (1,500 rpm for 10 min). Super-
natants were subsequently passed through a 0.45-m filter.
Establishment of the KSHV-THP-1 cell line. THP-1 cells were cul-
tured in RPMI with 10% fetal bovine serum (FBS) and were maintained at
37°C in a 5% CO2 environment. The rKSHV.219 produced from KSHV-
Vero cells was used to infect THP-1 cells. We first made an infection
cocktail containing complete RPMI medium and rKSHV.219 superna-
tants (volume ratio of 1:2) with 4 g/ml Polybrene. THP-1 cells were
centrifuged at 1,500 rpm for 5 min, and then 2  106 THP-1 cells were
resuspended in 3 ml infection cocktail and added to one well of a 6-well
plate. The cells in the 6-well plate were spun for 90 min at 30°C at 2,500
rpm; then, the supernatants were removed and the cells were resuspended
in 3 ml complete RPMI medium. The cells were incubated at 37°C for 72
h and then selected in complete RPMI medium containing 1.0 g/ml
puromycin for 3 to 5 weeks to establish stable KSHV-THP-1 cells. Once
THP-1 cells were 100% KSHV positive, KSHV-THP-1 cells were main-
tained in 0.1 g/ml puromycin, which is necessary for 12-O-
tetradecanoylphorbol-13-acetate (TPA)-induced reactivation. THP-1
control cells and KSHV-THP-1 cells were synchronously passaged.
Immunofluorescence assays. THP-1 or KSHV-THP-1 cells (1  104)
were air dried onto microscope slides and then fixed with 0.4% formalde-
hyde for 30 min. Cells were washed twice with phosphate-buffered saline
(PBS) for 5 min each, permeabilized with PBS, 0.1% Triton X-100 for 20
min, and washed twice with PBS, 1% bovine serum albumin (BSA) for 5
min each. Incubation with primary antibody anti-HHV8 open reading
frame 73 (ORF73) (Advanced Biotechnologies) (1:500) was performed
for 16 h at 4°C. Cells were washed twice with PBS, 1% BSA for 5 min each
and incubated with anti-rat tetramethyl rhodamine isothiocyanate
(TRITC)-conjugated secondary antibody (Sigma), 1:500, for 1 h at room
temperature. Cells were washed twice with PBS, 1% BSA for 5 min each
and then stained with 4=,6-diamidino-2-phenylindole (DAPI) for 2 min.
Next, cells were washed with PBS, 1% BSA for 5 min, followed by double-
distilled water (ddH2O) for 5 min. Microscope slides were mounted using
Vectashield (Vector Laboratories) mounting medium and visualized us-
ing a Nikon Microphot FXA upright fluorescence microscope.
Quantitative real-time-PCR (qPCR). DNase-treated total cellular
RNAs (1 g) from THP-1 or KSHV-THP-1 cells were reverse transcribed
into cDNA using a reverse transcription system from Promega. The real-
time PCR was done with an ABI 7300 real-time PCR machine using SYBR
green PCR master mix (Applied Biosystems). PCR was carried out with 1
cycle of 50°C for 2 min and 95°C for 10 min, followed by 40 cycles of 95°C
for 15 s and 60°C for 1 min. All fold activations were normalized by
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) expression in the
samples, and all of the PCR products were resolved using 1% agarose gels.
Viral gene profiling. THP-1 or KSHV-THP-1 cells (1  106) were
harvested, and total RNA was isolated with an RNeasy kit (Qiagen) ac-
cording to the manufacturer’s instructions and then DNase treated using
a DNA-free RNA kit (Zymo Research). The cDNA was synthesized using
a high-capacity cDNA reverse transcription kit (Applied Biosystems) as
directed by the manufacturer.
Detailed methods for real-time qPCR arrays and primer names were
described previously (11, 12). The primer name is as published before or
indicates the orf name in KSHV followed by position of the forward
primer. In addition, the original primer set was replaced with improved
primers for orf 11 (KS1008-1), orf20 (kshv10021-1), orf33 (kshv10034-1),
orf50 (kshv10052-1), orf53 (kshv10055-1), orf63 (kshv10069-1), orf65
(kshv10070-1), orf71 (kshv10076-1), orf K5 (kshv10014-1), and orf K15
(kshv10082-1). Primer sequences are available from the UNC Vironomics
core. Cycle threshold (CT) values were determined by automated analysis.
The threshold was set to five times the standard deviation (SD) of the
nontemplate control (NTC). For each qPCR run, dissociation curves were
analyzed to verify that identical primer-specific, single reaction products
were generated in each run. Genes with multiple primer pairs indicate two
independent primer sets. Samples were normalized to GAPDH levels,
centered by median of gene, and ordered by hierarchical clustering using
ArrayMiner (Optimal Design, Inc., Brussels, Belgium) software with stan-
dard correlation metrics (11, 12). Further statistical analysis was con-
ducted using the R programming environment (v 2.5.1).
Flow cytometry. To assess the expression of cell surface receptors,
THP-1 and KSHV-THP-1 monocytes were suspended at 1  107 cells/ml
in staining buffer (1 PBS, 2% BSA) and labeled with 20 l of mouse
allophycocyanin-conjugated anti-human CD86 (BD Pharmingen),
mouse allophycocyanin-conjugated anti-human CD83 (BD Pharmin-
gen), or isotype control allophycocyanin-conjugated IgG1 kappa (BD
Pharmingen) antibody for 30 min at 4°C, protected from light. Cells were
then thoroughly washed twice with staining buffer by centrifugation at
1,500 rpm at 4°C. Next, labeled cells were fixed using 1% formaldehyde for
30 min at 4°C, followed by washing with staining buffer. Samples were
resuspended in 250 l of staining buffer and analyzed using a BD FACs
Calibur (BD Biosciences) flow cytometer with data analysis using Summit
version 4.3 (Dako). Data were acquired for a minimum of 25,000 total
events. Cell sorting was performed by staining cells as described above for
CD86, and results were analyzed by the UNC Flow Cytometry Core facil-
ity using iCyt/Sony Reflection under sterile conditions.
Western blotting. THP-1 or KSHV-THP-1 cells were washed in ice-
cold 1 PBS and lysed by 3 dry ice-ethanol fractionations in radioim-
munoprecipitation assay (RIPA) lysis buffer. Cell lysates were centrifuged
at 13,000 rpm, 4°C for 10 min. Protein quantifications were performed
using the Bradford protein quantification assay. Whole-cell lysate (25 g)
was resolved by SDS-polyacrylamide gel electrophoresis and transferred
to nitrocellulose membranes by wet transfer at 30 V overnight at 4°C.
Transfers were verified by Ponceau S staining, followed by blocking in 5%
nonfat dry milk (NFDM), 1 PBS, 0.2% Tween 20. Following three
washes in 1 PBS, 0.2% Tween 20 for 10 min each at room temperature,
membranes were incubated with primary antibody overnight at 4°C.
Rabbit monoclonal anti-human CD86 (Novus Biologicals) or rabbit
monoclonal anti-human CD80 (Novus Biologicals) was diluted in 5%
NFDM at 1:5,000 or 1:10,000, respectively. Following incubations,
membranes were washed three times and incubated with peroxidase-
conjugated, anti-rabbit IgG (Cell Signaling) in 5% NFDM at 1:2,000
for 1 h at room temperature. Following the three washes, membranes
were developed using Amersham ECL Plus Western blotting detection
reagents (GE Healthcare). Viral protein K8.1 was detected using
mouse K8.1 monoclonal antibody (ABI Biologicals) diluted 1:1,000 in
5% NFDM overnight at 4°C, followed by peroxidase-conjugated, anti-
mouse IgG as described above.
Cytokine expression analysis. THP-1 or KSHV-THP-1 cells (1 
106) were plated in 12-well plates containing complete medium. After
incubation at 37°C for 24 h, supernatants were harvested and cleared of
cell debris by centrifugation at 1,250 rpm for 10 min. Supernatants were
analyzed for cytokine expression using Millipore Luminex multianalyte
technology according to the manufacturer’s instructions.
KSHV reactivation. KSHV-THP-1 cells (1  106) were plated in 12-
well plates in growth medium lacking puromycin and treated with either
dimethyl sulfoxide (DMSO) or 20 ng/ml TPA for up to 120 h. After 48 h
and 72 h, reactivation was determined by qPCR as described above, using
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viral interleukin-6 (IL-6) primers and GAPDH endogenous controls.
PCR products were analyzed by 1.2% agarose gel electrophoresis. Viral
K8.1 protein expression was analyzed 120 h after TPA treatment as de-
scribed above.
RESULTS
KSHV can successfully infect human monocytes and macro-
phages in vitro and in vivo (4–6, 25). We infected THP-1 cells with
rKSHV.219, expressing green fluorescent protein (GFP) driven by
the CMV promoter, red fluorescent protein (RFP) under a lytic
viral promoter, and the puromycin resistance gene (40). Seventy-
two hours postinfection, cells were added to puromycin-
containing selection medium to maintain KSHV infection and to
achieve a 100% KSHV-infected monocytic cell line as monitored
by GFP expression (Fig. 1A).
To confirm KSHV infection of THP-1 cells, we performed im-
munofluorescence assays on KSHV-infected and uninfected
THP-1 cells for LANA protein expression (Fig. 1B). Briefly,
KSHV-THP-1 or THP-1 cells suspended in PBS were spotted on
slides, air dried, and fixed with paraformaldehyde. Cells were
stained with an antibody directed against LANA followed by a
TRITC-conjugated secondary antibody. Cells were also stained
with DAPI to demarcate the nucleus. As can be seen in Fig. 1B,
uninfected THP-1 cells did not show any LANA staining, while the
KSHV-THP-1 cells showed characteristic nuclear speckled stain-
ing for LANA protein (19).
In order to determine the profile of KSHV viral genes expressed
in the THP-1 monocytic cell line, qPCR was performed on KSHV-
THP-1 cells and uninfected THP-1 cells. qPCR primer pairs were
designed for each KSHV ORF as previously described (11). Equal
amounts of total poly(A) mRNA from THP-1 and KSHV-THP-1
FIG 1 KSHV infection in THP-1 cells. (A) Fluorescence microscopy of GFP expression in KSHV-THP-1 cells compared to that in uninfected THP-1 control
cells. (B) Immunofluorescence staining of KSHV LANA expression in KSHV-THP-1 cells compared to that in uninfected THP-1 cells. Images were obtained at
20 magnification.
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cells were used as starting material. Figure 2A shows cycle thresh-
old (CT) values for each KSHV gene versus the relative log fold
gene expression in KSHV-THP-1 cells compared to that in unin-
fected THP-1 cells. The LANA gene and several other classic latent
genes, including vCyclin and vIRF-3 genes, were detected at high
levels in the KSHV-THP-1 cells. Note that cellular gapdh and hprt,
the positive controls, were present at a ratio of 1, i.e., at equal
expression levels in infected and uninfected cells. Figure 2B shows
the density distributions, i.e., the number of genes with a given
expression level above that for uninfected cells. Fewer than 10
transcripts were expressed at levels significantly greater than 100
times that of the uninfected control cells (Fig. 2B, dotted line); the
FIG 2 KSHV gene expression profile of KSHV-THP-1 cells. (A) Analysis of log KSHV gene expression versus qPCR cycle threshold (CT) value. Dotted line
represents limit of detection for viral genes. (B) Density distribution (on the vertical axis) of relative log fold change in gene expression (on the horizontal axis)
in KSHV-THP-1 cells compared to that in uninfected THP-1 cells for each KSHV-specific primer pair. Also shown is the 95% CI (104.99 . . . 103.64) between the
genes that are highly expressed (100-fold above uninfected control) and those that are moderately expressed (100-fold) or that were undetectable under both
conditions and the difference between these two groups based on nonparametric test. (C) Heat map depicting KSHV transcription in KSHV-THP-1 cells
compared to that in uninfected control for each open reading frame. Gene expression is represented by the following colors: red, high; white, intermediate; blue,
undetectable. Each condition depicts two biological replicates. Rows indicate the primers, which were labeled using the name of the KSHV orf followed by a
position of the forward primer.
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remainder of genes were undetectable or present at low levels
(100-fold of level for mock-infected cells). The difference be-
tween these two groups of genes was significant to a P value of
2.4  109, with a 95% confidence interval (95% CI) between
the means of expression of 104.99 and 103.64. Relative expression
levels are depicted by heat maps comparing KSHV-THP-1 and
THP-1 cells (Fig. 2C). Lytic transcripts detected at high to mod-
erate expression levels likely reflect the low number of cells spon-
taneously reactivating, similar to results for other KSHV-infected
cell lines in culture (33). Importantly, KSHV-THP-1 cells were
capable of reactivation after treatment with 20 ng/ml TPA (Fig.
3A), as evidenced by measuring viral IL-6 mRNA levels after 48 h
and 72 h compared to GAPDH mRNA levels as the endogenous
control. No signal was obtained in the absence of reverse tran-
scription (RT) or absence of template (NTC). Lytic viral protein
expression of KSHV K8.1 could also be detected in the TPA-
reactivated cells (Fig. 3B).
Primary infection of dendritic cells and macrophages with
KSHV has been shown to downregulate DC-SIGN, and in B cells
KSHV infection decreased MHC I (31, 32). Hence, we investigated
whether latently infected monocytes show downregulation of
monocyte activation markers. We found that surface expression
of CD86 was reduced from approximately 31% in THP-1 cells to
4% for KSHV-THP-1 cells (average fold change, 5.02  2.4) (Fig.
4). Additionally, we observed that surface expression of CD83 was
downregulated from 12% to 1.20% in KSHV-THP-1 cells com-
pared with that in uninfected control cells (average fold change,
5.1  4.0). Since KSHV-infected monocytes are prevalent in KS
lesions, reduced expression of costimulatory molecules on the
surface of antigen-presenting cells, such as monocytes, during la-
tency may dampen host immune responses against KSHV-
infected cells.
In order to confirm coreceptor downregulation, we performed
reverse transcription-qPCR (RT-qPCR) for these markers as well
as additional costimulatory markers CD80 and CD1a (Fig. 5). We
FIG 3 TPA treatment of KSHV-THP-1 cells results in lytic replication. (A)
Reactivation of KSHV-THP-1 cells. PCR analysis of KSHV lytic gene for vIL-6
at 48 h and 72 h after TPA treatment. (B) KSHV-THP-1 or BCBL-1 control
cells (1  106) were treated with 20 ng/ml TPA (T) or mock treated with
DMSO (M). One hundred twenty hours later, K8.1 protein expression was
analyzed by immunoblotting.
FIG 4 KSHV-THP-1 cells exhibit reduced CD86 and CD83 costimulatory molecule expression. THP-1 (A) or KSHV-THP-1 (B) cells were incubated with
isotype control, CD86, or CD83 antibody, followed by anti-mouse allophycocyanin-conjugated secondary antibody. Cell surface expression of CD86 and CD83
compared to that seen with the isotype control was analyzed by flow cytometry. Representative data are shown.
FIG 5 Latent KSHV inhibits expression of costimulatory molecules. (A)
qPCR analysis for expression of CD86, CD80, CD83, and CD1a in KSHV-
THP-1 cells (K) compared to that in uninfected THP-1 control cells (T). (B)
Expression of CD86 and CD80 was determined by immunoblot analysis of
KSHV-THP-1 cells compared to uninfected THP-1 control cells.
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found that several genes associated with macrophage/dendritic
cell activation were downregulated compared to levels in unin-
fected THP-1 control cells (Fig. 5A). By densitometry, we found
that genes for costimulatory molecules CD80, CD86, CD1a, and
CD83 were downregulated 2.9-, 8.1-, 2.7-, and 4.1-fold, respec-
tively. The downregulation of CD86 and CD80 basal protein ex-
pression levels in KSHV-THP-1 cells was confirmed by Western
blot analysis (Fig. 5B).
There is a heterogeneous level of CD86 coreceptor expression
on THP-1 cells. Our findings may allow for the alternative possi-
bility that KSHV selectively enters cells with low CD86 expression
and that KSHV-infected latent THP-1 cells display a low CD86
expression due to this fact. To rule out this possibility, THP-1 cells
were stained for CD86, and the cells that expressed the highest
levels of CD86 coreceptor were isolated using fluorescence-
activated cell sorting (FACS). This population is denoted as
CD86hi THP-1 (Fig. 6A). Sorted CD86hi THP-1 cells were then
infected with KSHV and analyzed by flow cytometry for GFP ex-
pression (Fig. 6B). CD86hi THP-1 cells were 68.6% GFP positive
24 h postinfection, suggesting that KSHV can enter the fraction of
THP-1 cells with the highest level of CD86 surface expression
prior to establishing latency. Hence, it is more likely that CD86 is
downregulated by KSHV and that this effect is not an artifact of
KSHV preferentially entering THP-1 cells that express the smallest
amount of CD86 on their surface.
We also investigated cytokine expression in KSHV-THP-1 cells
compared to that in THP-1 controls by Luminex multianalyte
analysis. THP-1 or KSHV-THP-1 cells were incubated for 24 h
and cell-free supernatants collected for analysis. Overall, we ana-
lyzed the expression of 15 proinflammatory cytokines, and for the
most part, expression was unchanged (data not shown). However,
a significant difference in tumor necrosis factor alpha (TNF-)
and interleukin-1 (IL-1) was observed (Fig. 7A). TNF- and
IL-1 expression levels were 7.73  0.56 pg/ml and 4.90  0.59
pg/ml, respectively, in THP-1 cells, and these cytokines were un-
detectable in KSHV-THP-1 cells. In order to confirm that these
cytokines were downregulated at the transcription level, RT-PCR
analysis was performed. Figure 7B shows that transcription of
both genes is suppressed in KSHV-infected THP-1 cells. TNF-
and IL- are involved in upregulating the transcription of genes
involved in inflammation, hematopoiesis, and immune re-
sponses, including costimulatory molecules, and therefore their
downregulation may contribute to inhibition of adaptive immu-
nity.
DISCUSSION
KSHV establishes a lifelong persistent infection in the human
host. The virus can establish latency in a number of different cell
types, including B cells, monocytes, and epithelial and endothelial
cells. Previous studies have analyzed cellular and viral gene expres-
sion in lytically and latently infected B cells and endothelial cells
(7, 12, 27, 29). Here we report viral gene profiling of a KSHV
latently infected monocytic cell line. We observed that KSHV-
THP-1 cells predominantly expressed a latent viral gene profile
with low levels of lytic replication, which we attribute to sponta-
neous reactivation. We found that KSHV-THP-1 cells display re-
duced expression of several cellular proteins involved in inflam-
mation and immunity, compared to expression in uninfected
cells. This suggests that viral proteins may downregulate expres-
sion of genes that could lead to detection of the virus by the host
immune system.
FIG 6 KSHV does not require low surface coreceptor expression to infect THP-1 monocytes. (A) THP-1 cells (1  107) were stained with CD86 antibody and
immediately analyzed by fluorescence-activated cell sorting (FACS) to separate THP-1 cells with the highest levels of CD86 expression (square, 1.43%). (B) The
CD86hi THP-1 cells were then infected with KSHV and analyzed for GFP expression by flow cytometry to determine infection. y axis units are numbers of cells.
FIG 7 Expression of select cytokines in KSHV-THP-1 cells. (A) TNF- and
IL-1 expression in THP-1 compared to KSHV-THP-1 cells was determined
by Luminex multianalyte assay. Units shown are average pg/ml. (B) KSHV-
THP-1 (K) or THP-1 (T) cells were harvested and analyzed by PCR for expres-
sion of downregulated TNF-, IL-1, and GAPDH gene transcripts. Following
PCR, samples were subjected to gel electrophoresis using 1% agarose gels.
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KSHV-specific cytotoxic T lymphocyte (CTL) responses are
reduced in KS patients compared to responses in KSHV-positive
asymptomatic individuals, suggesting that failure to mount a
CTL-mediated immune response contributes to development of
disease (17). After recognition of a T cell’s cognate antigen in the
context of major histocompatibility complex (MHC) on the sur-
face of APCs, engagement of CD86 or CD80 provides a necessary
costimulatory signal for CTL activation (16, 34). Monocytes help
dictate CTL action, since they contribute to their stimulation by
upregulating costimulatory molecules, such as CD80 and CD86,
upon pathogen detection. Furthermore, monocytes are recruited
to sites of T cell activation and are capable of differentiating into
macrophages and dendritic cells, which are potent antigen-
presenting cells necessary for an effective cell-mediated immune
response (14).
Previous studies have shown that viral infection reduces ex-
pression of several cell surface immune receptors. Varicella-zoster
virus (VZV) infection of mature DCs results in selective down-
regulation of expression of functional immune molecules, includ-
ing MHC I, CD80, CD83, and CD86 (25). Herpes simplex virus 2
(HSV-2) infection causes the downregulation of MHC I and II,
CD40, CD80, and CD86 on mature DCs (25), although HSV-1
infection of mature DCs results in downregulation of only CD83
(21). Human cytomegalovirus (HCMV) has been shown to down-
regulate MHC I and II, CD40, CD80, CD86, and CD83 on
monocyte-derived mature DCs generated by treatment with lipo-
polysaccharide (LPS) and TNF- (26, 30); at the same time, pro-
ductive infection in THP-1 cells induces IL-1 and TNF- (15,
18). In addition, during acute HIV-1 infection, lymphoid tissue
has reduced CD80 and CD86 expression (23). KSHV infection of
myeloid-derived macrophages and dendritic cells results in a re-
duction in differentiation and antigen presentation to CTLs (9,
32). Similarly, our study shows that KSHV latent infection of
monocytic THP-1 cells leads to significant downregulation of
CD1A, CD80, CD83, and CD86. Thus, it appears that human
herpesviruses have multiple strategies to interfere with detection
by the host immune system and that KSHV is no exception. Infec-
tion of monocytes and suppression of cellular mechanisms of im-
mune recognition during latency suggest that KSHV specifically
targets APCs to prevent activation of antiviral responses in order
to support long-term dormant infection.
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